Table 4. Multivariate analysis.
Progression Free Survival | Overall Survival | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age (< 60 or ≥ 60) | 1.361 | 0.973–1.904 | 0.072 | 1.501 | 1.082–2.083 | 0.015 |
Operation (yes or no) | 1.121 | 0.784–1.603 | 0.531 | 1.756 | 1.202–2.564 | 0.004 |
Type (diffuse or intestinal) | 1.095 | 0.901–1.331 | 0.363 | 0.941 | 0.769–1.151 | 0.552 |
Number of metastasis (1 or > 1) | 1.274 | 1.034–1.568 | 0.023 | 1.042 | 0.843–1.289 | 0.703 |
IGFBP1 rs4619 (AA or AG/GG) | 0.575 | 0.385–0.858 | 0.007 | 0.707 | 0.484–1.031 | 0.072 |
IGF1R rs7166558 (AA/AG or GG) | 0.809 | 0.181–3.617 | 0.782 | 1.874 | 0.245–14.31 | 0.545 |
IGF1R rs2229765 (AA or AG/GG) | 1.004 | 0.241–4.183 | 0.996 | 2.563 | 0.347–18.93 | 0.356 |
IGF1R rs12437963 (AA or AG/GG) | 1.114 | 0.694–1.789 | 0.655 | 1.139 | 0.705–1.843 | 0.595 |
IGF1R rs2872060 (GG/GT or TT) | 1.379 | 0.849–2.240 | 0.195 | 1.708 | 1.024–2.850 | 0.040 |
IGF1R rs17847203 (CC or CT) | 2.530 | 1.289–4.966 | 0.007 | 2.087 | 1.070–4.069 | 0.031 |